Dr. Eric Mininberg, MD

Expert Publications

• Effect of inhibition of ornithine decarboxylase activity in a model of acute hepatocellular necrosis.

Media Releases

Get to know Oncologist Dr. Eric Mininberg, who serves patients throughout the State of Georgia.

A leader in the field of medical oncology, Dr. Mininberg diagnoses and treats patients with all cancer types. He joined Piedmont Cancer Institute in 2003 and now serves as the President. He currently sees patients at their offices in Atlanta and Stockbridge, Georgia.

The physicians and advanced practitioners at Piedmont Cancer Institute work closely with patients’ entire treatment team of specialists, primary care physicians, family, and caregivers to address their individualized cancer treatment plan. They integrate leading-edge therapies, the latest clinical trials, and cancer wellness programs for the best care possible.

Throughout his academic career, Dr. Mininberg graduated with his medical degree from the University of Virginia School of Medicine, and completed his residency in internal medicine at the same educational venue. He then went on to complete his fellowship in hematology at Baylor University, and his fellowship in medical oncology at the University of Texas MD Anderson Cancer Center.

In pursuit of clinical excellence, the doctor is board-certified in medical oncology, hematology, and internal medicine by the American Board of Internal Medicine (ABIM). The ABIM is a physician-led, non-profit, independent evaluation organization driven by doctors who want to achieve higher standards for better care in a rapidly changing world.

Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. A medical professional who practices oncology is an oncologist. An oncologist is a doctor who treats cancer and provides medical care for a person diagnosed with cancer. They lead a cancer treatment team of various healthcare professionals, treat patients with radiation therapy, coordinate treatment plans and prescribe various types of treatment, including chemotherapy and immunotherapy, as well as assist patients with pain management.

A recipient of numerous awards and honors, Dr. Mininberg was inducted as a member of the Cum Laude Society with St. Albans School in Washington, DC in 1989. While at The University of Texas MD Anderson Cancer Center, he was honored with the Elsa U. Pardee Foundation Grant for Community Oncology. As a fellow in 2003, he was awarded the American Society of Clinical Oncology Merit Award.

Happily married, he and his wife have two children. In his free time, he enjoys cooking and playing with his large friendly rescue retriever mix, Nickel.

Recommended Articles

• Can Multiple Myeloma be Asymptomatic?

  Early treatment for persons suffering from multiple myeloma that is asymptomatic may not be beneficial. The initial stages for multiple myeloma do not show symptoms, and this is known as being asymptomatic.The treatment for persons with asymptomatic multiple myeloma should be deferred up to when the...

• Teen with Hodgkin Lymphoma Skates with Her Hero, Mario Lemieux

  Lillian Tarasiewicz was diagnosed with stage 3B Hodgkin lymphoma in October of 2015. She currently resides in South Carolina, but because of her father’s Pennsylvania background, she grew up with a love for hockey and for the Pittsburgh Penguins. She always felt a special connection to Mario...

• Bringing Chronic Lymphocytic Leukemia Patients and Their Doctors Together via Survey

  While patients may entirely admire and respect their doctors, sometimes they simply do not agree with the course of action they are proposing. While this may not be a big deal for a visit about a cold or something minimal, it can be life-altering for those with chronic conditions. That is why a...

• Living with Lymphoma Day by Day

  A majority of individuals diagnosed with lymphoma find that they have to make a great deal of adjustments to their lives. There are several physical, emotional, social, and everyday obstacles from diagnosis to remission.Living with lymphoma can be different for every individual, which is why it is...

• Treatment Update for Hodgkin Lymphoma

  Over time, research has uncovered ways of treating Hodgkin lymphoma (HL) to produce an 80% to 90% cure rate. For the remaining 10% to 20% who are either resistant to the primary treatment or have relapsed, their cancer can still be fatal.The standard care for those not yet cured has been a two-step...

• Living as a Hodgkin Lymphoma Survivor: Creating a New Normal

  No one can ever truly be prepared for what it is like to live with cancer. Even the strongest survivors face setbacks, and some of the fiercest warriors share their stories of how they find their "new normals."Kimberly's storyWhen she was only 25, just five days before her wedding, Kimberly felt a...